nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ALB—chronic obstructive pulmonary disease	0.215	1	CbGaD
Glyburide—SLCO2B1—Montelukast—chronic obstructive pulmonary disease	0.139	0.275	CbGbCtD
Glyburide—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0448	0.0883	CbGbCtD
Glyburide—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0423	0.0834	CbGbCtD
Glyburide—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0337	0.0665	CbGbCtD
Glyburide—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0337	0.0665	CbGbCtD
Glyburide—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.028	0.0553	CbGbCtD
Glyburide—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.028	0.0553	CbGbCtD
Glyburide—CFTR—sweat—chronic obstructive pulmonary disease	0.0272	0.393	CbGeAlD
Glyburide—ALB—Prednisone—chronic obstructive pulmonary disease	0.0218	0.0431	CbGbCtD
Glyburide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0215	0.0424	CbGbCtD
Glyburide—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0213	0.0419	CbGbCtD
Glyburide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0145	0.0287	CbGbCtD
Glyburide—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0142	0.0279	CbGbCtD
Glyburide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0139	0.0273	CbGbCtD
Glyburide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0124	0.0244	CbGbCtD
Glyburide—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0121	0.0239	CbGbCtD
Glyburide—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0114	0.0225	CbGbCtD
Glyburide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00725	0.0143	CbGbCtD
Glyburide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00685	0.0135	CbGbCtD
Glyburide—KCNJ5—respiratory system—chronic obstructive pulmonary disease	0.00503	0.0727	CbGeAlD
Glyburide—ABCC9—smooth muscle tissue—chronic obstructive pulmonary disease	0.00307	0.0444	CbGeAlD
Glyburide—KCNJ5—lung—chronic obstructive pulmonary disease	0.00267	0.0386	CbGeAlD
Glyburide—ABCA1—respiratory system—chronic obstructive pulmonary disease	0.00259	0.0374	CbGeAlD
Glyburide—CPT1A—connective tissue—chronic obstructive pulmonary disease	0.00244	0.0353	CbGeAlD
Glyburide—CFTR—respiratory system—chronic obstructive pulmonary disease	0.00244	0.0353	CbGeAlD
Glyburide—ABCA1—connective tissue—chronic obstructive pulmonary disease	0.00228	0.0329	CbGeAlD
Glyburide—Leukocytoclastic vasculitis—Montelukast—chronic obstructive pulmonary disease	0.00214	0.0183	CcSEcCtD
Glyburide—Heartburn—Aminophylline—chronic obstructive pulmonary disease	0.00204	0.0175	CcSEcCtD
Glyburide—ABCC9—lung—chronic obstructive pulmonary disease	0.00203	0.0293	CbGeAlD
Glyburide—CFTR—bronchus—chronic obstructive pulmonary disease	0.00201	0.0291	CbGeAlD
Glyburide—CFTR—trachea—chronic obstructive pulmonary disease	0.00181	0.0261	CbGeAlD
Glyburide—Gliclazide—VEGFA—chronic obstructive pulmonary disease	0.0017	0.457	CrCbGaD
Glyburide—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00166	0.0142	CcSEcCtD
Glyburide—CPT1A—lung—chronic obstructive pulmonary disease	0.00147	0.0213	CbGeAlD
Glyburide—Heartburn—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.0126	CcSEcCtD
Glyburide—ABCA1—lung—chronic obstructive pulmonary disease	0.00137	0.0198	CbGeAlD
Glyburide—Coagulopathy—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.0111	CcSEcCtD
Glyburide—CFTR—lung—chronic obstructive pulmonary disease	0.0013	0.0187	CbGeAlD
Glyburide—ABCC3—respiratory system—chronic obstructive pulmonary disease	0.00128	0.0184	CbGeAlD
Glyburide—ABCC8—smooth muscle tissue—chronic obstructive pulmonary disease	0.00122	0.0177	CbGeAlD
Glyburide—SLCO2B1—respiratory system—chronic obstructive pulmonary disease	0.00119	0.0172	CbGeAlD
Glyburide—Vasculitis—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00922	CcSEcCtD
Glyburide—Arthritis—Tiotropium—chronic obstructive pulmonary disease	0.000991	0.0085	CcSEcCtD
Glyburide—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.000922	0.00791	CcSEcCtD
Glyburide—Zafirlukast—CYP1A2—chronic obstructive pulmonary disease	0.000918	0.247	CrCbGaD
Glyburide—SLC15A2—respiratory system—chronic obstructive pulmonary disease	0.000908	0.0131	CbGeAlD
Glyburide—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000864	0.00741	CcSEcCtD
Glyburide—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.000842	0.00723	CcSEcCtD
Glyburide—Arthritis—Formoterol—chronic obstructive pulmonary disease	0.000799	0.00686	CcSEcCtD
Glyburide—Arthritis—Arformoterol—chronic obstructive pulmonary disease	0.000799	0.00686	CcSEcCtD
Glyburide—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000796	0.00683	CcSEcCtD
Glyburide—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000796	0.00683	CcSEcCtD
Glyburide—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000785	0.00674	CcSEcCtD
Glyburide—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000752	0.00645	CcSEcCtD
Glyburide—SLC15A2—bronchus—chronic obstructive pulmonary disease	0.000747	0.0108	CbGeAlD
Glyburide—ABCC1—bronchus—chronic obstructive pulmonary disease	0.000739	0.0107	CbGeAlD
Glyburide—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000738	0.00633	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000685	0.00588	CcSEcCtD
Glyburide—ABCC3—lung—chronic obstructive pulmonary disease	0.000677	0.00979	CbGeAlD
Glyburide—SLC15A2—trachea—chronic obstructive pulmonary disease	0.000671	0.00969	CbGeAlD
Glyburide—ABCC1—trachea—chronic obstructive pulmonary disease	0.000663	0.00959	CbGeAlD
Glyburide—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000662	0.00568	CcSEcCtD
Glyburide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000654	0.00561	CcSEcCtD
Glyburide—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000651	0.00559	CcSEcCtD
Glyburide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00065	0.00558	CcSEcCtD
Glyburide—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.000645	0.00554	CcSEcCtD
Glyburide—Bezafibrate—CYP1A1—chronic obstructive pulmonary disease	0.000643	0.173	CrCbGaD
Glyburide—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000642	0.00551	CcSEcCtD
Glyburide—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.000638	0.00548	CcSEcCtD
Glyburide—SLCO2B1—lung—chronic obstructive pulmonary disease	0.000631	0.00912	CbGeAlD
Glyburide—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000624	0.00536	CcSEcCtD
Glyburide—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000622	0.00534	CcSEcCtD
Glyburide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00062	0.00532	CcSEcCtD
Glyburide—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.000618	0.0053	CcSEcCtD
Glyburide—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000615	0.00528	CcSEcCtD
Glyburide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000598	0.00513	CcSEcCtD
Glyburide—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000595	0.00511	CcSEcCtD
Glyburide—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.000594	0.0051	CcSEcCtD
Glyburide—SLCO1A2—lung—chronic obstructive pulmonary disease	0.000581	0.00839	CbGeAlD
Glyburide—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00058	0.00498	CcSEcCtD
Glyburide—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000576	0.00494	CcSEcCtD
Glyburide—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000572	0.00491	CcSEcCtD
Glyburide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000554	0.00476	CcSEcCtD
Glyburide—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000551	0.00473	CcSEcCtD
Glyburide—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000546	0.00469	CcSEcCtD
Glyburide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00054	0.00463	CcSEcCtD
Glyburide—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000533	0.00457	CcSEcCtD
Glyburide—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00053	0.00455	CcSEcCtD
Glyburide—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000526	0.00452	CcSEcCtD
Glyburide—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00445	CcSEcCtD
Glyburide—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00445	CcSEcCtD
Glyburide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000515	0.00442	CcSEcCtD
Glyburide—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000494	0.00424	CcSEcCtD
Glyburide—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000494	0.00424	CcSEcCtD
Glyburide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000494	0.00424	CcSEcCtD
Glyburide—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000492	0.00422	CcSEcCtD
Glyburide—SLC15A2—lung—chronic obstructive pulmonary disease	0.000482	0.00696	CbGeAlD
Glyburide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000478	0.00411	CcSEcCtD
Glyburide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000478	0.00411	CcSEcCtD
Glyburide—ABCC1—lung—chronic obstructive pulmonary disease	0.000477	0.00689	CbGeAlD
Glyburide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000474	0.00407	CcSEcCtD
Glyburide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000474	0.00407	CcSEcCtD
Glyburide—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000473	0.00406	CcSEcCtD
Glyburide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000471	0.00405	CcSEcCtD
Glyburide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000469	0.00402	CcSEcCtD
Glyburide—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000468	0.00402	CcSEcCtD
Glyburide—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000468	0.00402	CcSEcCtD
Glyburide—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000466	0.004	CcSEcCtD
Glyburide—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000464	0.00398	CcSEcCtD
Glyburide—Gliclazide—ALB—chronic obstructive pulmonary disease	0.000456	0.123	CrCbGaD
Glyburide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000447	0.00384	CcSEcCtD
Glyburide—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000444	0.00381	CcSEcCtD
Glyburide—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000442	0.00379	CcSEcCtD
Glyburide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000442	0.00379	CcSEcCtD
Glyburide—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00044	0.00378	CcSEcCtD
Glyburide—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000438	0.00376	CcSEcCtD
Glyburide—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000438	0.00376	CcSEcCtD
Glyburide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000436	0.00374	CcSEcCtD
Glyburide—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000432	0.0037	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000431	0.0037	CcSEcCtD
Glyburide—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000429	0.00369	CcSEcCtD
Glyburide—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.00367	CcSEcCtD
Glyburide—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000428	0.00367	CcSEcCtD
Glyburide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000425	0.00365	CcSEcCtD
Glyburide—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000419	0.00359	CcSEcCtD
Glyburide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000416	0.00358	CcSEcCtD
Glyburide—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.00355	CcSEcCtD
Glyburide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00041	0.00352	CcSEcCtD
Glyburide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000408	0.00351	CcSEcCtD
Glyburide—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00346	CcSEcCtD
Glyburide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000399	0.00342	CcSEcCtD
Glyburide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000398	0.00342	CcSEcCtD
Glyburide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000398	0.00342	CcSEcCtD
Glyburide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.00342	CcSEcCtD
Glyburide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.00342	CcSEcCtD
Glyburide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000397	0.00341	CcSEcCtD
Glyburide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000397	0.0034	CcSEcCtD
Glyburide—ABCG2—lung—chronic obstructive pulmonary disease	0.000395	0.0057	CbGeAlD
Glyburide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00335	CcSEcCtD
Glyburide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00335	CcSEcCtD
Glyburide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000387	0.00332	CcSEcCtD
Glyburide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.00328	CcSEcCtD
Glyburide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000382	0.00328	CcSEcCtD
Glyburide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00323	CcSEcCtD
Glyburide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00323	CcSEcCtD
Glyburide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000376	0.00323	CcSEcCtD
Glyburide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000374	0.00321	CcSEcCtD
Glyburide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.00321	CcSEcCtD
Glyburide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000374	0.00321	CcSEcCtD
Glyburide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000374	0.00321	CcSEcCtD
Glyburide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00037	0.00317	CcSEcCtD
Glyburide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000367	0.00315	CcSEcCtD
Glyburide—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000366	0.0053	CbGeAlD
Glyburide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000366	0.00314	CcSEcCtD
Glyburide—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000366	0.00314	CcSEcCtD
Glyburide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00309	CcSEcCtD
Glyburide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000357	0.00306	CcSEcCtD
Glyburide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.00306	CcSEcCtD
Glyburide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000357	0.00306	CcSEcCtD
Glyburide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000355	0.00305	CcSEcCtD
Glyburide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000355	0.00304	CcSEcCtD
Glyburide—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000354	0.00304	CcSEcCtD
Glyburide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00304	CcSEcCtD
Glyburide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000349	0.00299	CcSEcCtD
Glyburide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00299	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000348	0.00299	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000348	0.00299	CcSEcCtD
Glyburide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00295	CcSEcCtD
Glyburide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000343	0.00295	CcSEcCtD
Glyburide—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000342	0.00293	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000341	0.00292	CcSEcCtD
Glyburide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00292	CcSEcCtD
Glyburide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00292	CcSEcCtD
Glyburide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.00289	CcSEcCtD
Glyburide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00289	CcSEcCtD
Glyburide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00289	CcSEcCtD
Glyburide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00288	CcSEcCtD
Glyburide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000335	0.00287	CcSEcCtD
Glyburide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00283	CcSEcCtD
Glyburide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00283	CcSEcCtD
Glyburide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00283	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.00282	CcSEcCtD
Glyburide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00278	CcSEcCtD
Glyburide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00277	CcSEcCtD
Glyburide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00276	CcSEcCtD
Glyburide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000319	0.00274	CcSEcCtD
Glyburide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00272	CcSEcCtD
Glyburide—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000317	0.00272	CcSEcCtD
Glyburide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000316	0.00272	CcSEcCtD
Glyburide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000316	0.00271	CcSEcCtD
Glyburide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000315	0.0027	CcSEcCtD
Glyburide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000315	0.0027	CcSEcCtD
Glyburide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000314	0.0027	CcSEcCtD
Glyburide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00269	CcSEcCtD
Glyburide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000312	0.00268	CcSEcCtD
Glyburide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.00268	CcSEcCtD
Glyburide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00267	CcSEcCtD
Glyburide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000306	0.00263	CcSEcCtD
Glyburide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.0026	CcSEcCtD
Glyburide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000303	0.0026	CcSEcCtD
Glyburide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000302	0.00259	CcSEcCtD
Glyburide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.00259	CcSEcCtD
Glyburide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000301	0.00258	CcSEcCtD
Glyburide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000298	0.00256	CcSEcCtD
Glyburide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000298	0.00256	CcSEcCtD
Glyburide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.00256	CcSEcCtD
Glyburide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00255	CcSEcCtD
Glyburide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00255	CcSEcCtD
Glyburide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000296	0.00254	CcSEcCtD
Glyburide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000296	0.00254	CcSEcCtD
Glyburide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00253	CcSEcCtD
Glyburide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00246	CcSEcCtD
Glyburide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.00245	CcSEcCtD
Glyburide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00241	CcSEcCtD
Glyburide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00241	CcSEcCtD
Glyburide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.00241	CcSEcCtD
Glyburide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000281	0.00241	CcSEcCtD
Glyburide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00237	CcSEcCtD
Glyburide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00235	CcSEcCtD
Glyburide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00235	CcSEcCtD
Glyburide—ABCB1—trachea—chronic obstructive pulmonary disease	0.000271	0.00391	CbGeAlD
Glyburide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00232	CcSEcCtD
Glyburide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00232	CcSEcCtD
Glyburide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000268	0.0023	CcSEcCtD
Glyburide—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000266	0.00228	CcSEcCtD
Glyburide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00228	CcSEcCtD
Glyburide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000265	0.00227	CcSEcCtD
Glyburide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00224	CcSEcCtD
Glyburide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00224	CcSEcCtD
Glyburide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000259	0.00222	CcSEcCtD
Glyburide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00222	CcSEcCtD
Glyburide—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00221	CcSEcCtD
Glyburide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000256	0.0022	CcSEcCtD
Glyburide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00219	CcSEcCtD
Glyburide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.00217	CcSEcCtD
Glyburide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00212	CcSEcCtD
Glyburide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00208	CcSEcCtD
Glyburide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00208	CcSEcCtD
Glyburide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00207	CcSEcCtD
Glyburide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00207	CcSEcCtD
Glyburide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00206	CcSEcCtD
Glyburide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00206	CcSEcCtD
Glyburide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000239	0.00205	CcSEcCtD
Glyburide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000239	0.00205	CcSEcCtD
Glyburide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.00205	CcSEcCtD
Glyburide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00204	CcSEcCtD
Glyburide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00202	CcSEcCtD
Glyburide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00202	CcSEcCtD
Glyburide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000234	0.00201	CcSEcCtD
Glyburide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.00199	CcSEcCtD
Glyburide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00197	CcSEcCtD
Glyburide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00195	CcSEcCtD
Glyburide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00195	CcSEcCtD
Glyburide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00195	CcSEcCtD
Glyburide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00195	CcSEcCtD
Glyburide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.00194	CcSEcCtD
Glyburide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00191	CcSEcCtD
Glyburide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.00188	CcSEcCtD
Glyburide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00184	CcSEcCtD
Glyburide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.00178	CcSEcCtD
Glyburide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.00175	CcSEcCtD
Glyburide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00172	CcSEcCtD
Glyburide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000198	0.0017	CcSEcCtD
Glyburide—ABCB1—lung—chronic obstructive pulmonary disease	0.000195	0.00281	CbGeAlD
Glyburide—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000187	0.0016	CcSEcCtD
Glyburide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00159	CcSEcCtD
Glyburide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000184	0.00158	CcSEcCtD
Glyburide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000184	0.00158	CcSEcCtD
Glyburide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000174	0.00149	CcSEcCtD
Glyburide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00146	CcSEcCtD
Glyburide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00146	CcSEcCtD
Glyburide—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00144	CcSEcCtD
Glyburide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.00141	CcSEcCtD
Glyburide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00137	CcSEcCtD
Glyburide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00135	CcSEcCtD
Glyburide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00135	CcSEcCtD
Glyburide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00131	CcSEcCtD
Glyburide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00129	CcSEcCtD
Glyburide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00127	CcSEcCtD
Glyburide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00126	CcSEcCtD
Glyburide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00125	CcSEcCtD
Glyburide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00123	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00118	CcSEcCtD
Glyburide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00116	CcSEcCtD
Glyburide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00114	CcSEcCtD
Glyburide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00112	CcSEcCtD
Glyburide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00112	CcSEcCtD
Glyburide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00112	CcSEcCtD
Glyburide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00111	CcSEcCtD
Glyburide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00106	CcSEcCtD
Glyburide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00105	CcSEcCtD
Glyburide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00105	CcSEcCtD
Glyburide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00102	CcSEcCtD
Glyburide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00102	CcSEcCtD
Glyburide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00095	CcSEcCtD
Glyburide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000925	CcSEcCtD
Glyburide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000913	CcSEcCtD
Glyburide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000883	CcSEcCtD
Glyburide—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.55e-05	0.00082	CcSEcCtD
Glyburide—Rash—Prednisone—chronic obstructive pulmonary disease	9.48e-05	0.000813	CcSEcCtD
Glyburide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.47e-05	0.000813	CcSEcCtD
Glyburide—Headache—Prednisone—chronic obstructive pulmonary disease	9.41e-05	0.000808	CcSEcCtD
Glyburide—Nausea—Prednisone—chronic obstructive pulmonary disease	8.93e-05	0.000766	CcSEcCtD
Glyburide—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4e-05	0.000452	CbGpPWpGaD
Glyburide—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.94e-05	0.000446	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.91e-05	0.000442	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.91e-05	0.000442	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	3.9e-05	0.000441	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.89e-05	0.00044	CbGpPWpGaD
Glyburide—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.87e-05	0.000438	CbGpPWpGaD
Glyburide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.86e-05	0.000436	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.83e-05	0.000433	CbGpPWpGaD
Glyburide—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.82e-05	0.000432	CbGpPWpGaD
Glyburide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.81e-05	0.000431	CbGpPWpGaD
Glyburide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.81e-05	0.000431	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.79e-05	0.000428	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—GCLC—chronic obstructive pulmonary disease	3.75e-05	0.000423	CbGpPWpGaD
Glyburide—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	3.73e-05	0.000421	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	3.73e-05	0.000421	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.73e-05	0.000421	CbGpPWpGaD
Glyburide—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.73e-05	0.000421	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.7e-05	0.000419	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.7e-05	0.000419	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	3.7e-05	0.000418	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.67e-05	0.000415	CbGpPWpGaD
Glyburide—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.67e-05	0.000415	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.65e-05	0.000413	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—GCLC—chronic obstructive pulmonary disease	3.63e-05	0.000411	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	3.62e-05	0.00041	CbGpPWpGaD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.57e-05	0.000404	CbGpPWpGaD
Glyburide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	3.55e-05	0.000402	CbGpPWpGaD
Glyburide—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.53e-05	0.000399	CbGpPWpGaD
Glyburide—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.48e-05	0.000394	CbGpPWpGaD
Glyburide—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	3.47e-05	0.000392	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.43e-05	0.000388	CbGpPWpGaD
Glyburide—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	3.42e-05	0.000387	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—CTGF—chronic obstructive pulmonary disease	3.42e-05	0.000386	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.39e-05	0.000383	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.37e-05	0.000381	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.32e-05	0.000376	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.32e-05	0.000375	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—CTGF—chronic obstructive pulmonary disease	3.31e-05	0.000375	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.3e-05	0.000373	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	3.29e-05	0.000371	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.28e-05	0.000371	CbGpPWpGaD
Glyburide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	3.26e-05	0.000369	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	3.26e-05	0.000368	CbGpPWpGaD
Glyburide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.21e-05	0.000362	CbGpPWpGaD
Glyburide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.16e-05	0.000357	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.15e-05	0.000356	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.12e-05	0.000352	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.05e-05	0.000345	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.05e-05	0.000345	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.04e-05	0.000344	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.03e-05	0.000342	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.01e-05	0.00034	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—GSTT1—chronic obstructive pulmonary disease	3e-05	0.000339	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.99e-05	0.000338	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—GCLC—chronic obstructive pulmonary disease	2.96e-05	0.000335	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.96e-05	0.000335	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.94e-05	0.000332	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.89e-05	0.000327	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.87e-05	0.000325	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.84e-05	0.000321	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.84e-05	0.000321	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.83e-05	0.00032	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.82e-05	0.000319	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.78e-05	0.000314	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.76e-05	0.000312	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CTGF—chronic obstructive pulmonary disease	2.7e-05	0.000305	CbGpPWpGaD
Glyburide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.67e-05	0.000302	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.65e-05	0.000299	CbGpPWpGaD
Glyburide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.64e-05	0.000298	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.63e-05	0.000297	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.59e-05	0.000293	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.59e-05	0.000293	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.55e-05	0.000288	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.53e-05	0.000286	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—ALB—chronic obstructive pulmonary disease	2.52e-05	0.000285	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—ALB—chronic obstructive pulmonary disease	2.52e-05	0.000285	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.52e-05	0.000285	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.51e-05	0.000284	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.5e-05	0.000283	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.49e-05	0.000281	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.47e-05	0.00028	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.47e-05	0.000279	CbGpPWpGaD
Glyburide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.46e-05	0.000278	CbGpPWpGaD
Glyburide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.42e-05	0.000274	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.41e-05	0.000273	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.41e-05	0.000272	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—NOS3—chronic obstructive pulmonary disease	2.41e-05	0.000272	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.4e-05	0.000272	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.39e-05	0.00027	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.39e-05	0.00027	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.34e-05	0.000265	CbGpPWpGaD
Glyburide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.33e-05	0.000263	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.3e-05	0.000261	CbGpPWpGaD
Glyburide—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.3e-05	0.00026	CbGpPWpGaD
Glyburide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.3e-05	0.00026	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.29e-05	0.000259	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.28e-05	0.000258	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.28e-05	0.000258	CbGpPWpGaD
Glyburide—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	2.26e-05	0.000255	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.26e-05	0.000255	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.25e-05	0.000254	CbGpPWpGaD
Glyburide—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.24e-05	0.000253	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.22e-05	0.000251	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.22e-05	0.000251	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.22e-05	0.000251	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.19e-05	0.000248	CbGpPWpGaD
Glyburide—ABCC1—Disease—KL—chronic obstructive pulmonary disease	2.1e-05	0.000237	CbGpPWpGaD
Glyburide—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.08e-05	0.000235	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.08e-05	0.000235	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.08e-05	0.000235	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.07e-05	0.000234	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.06e-05	0.000233	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.06e-05	0.000233	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.05e-05	0.000231	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.05e-05	0.000231	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.03e-05	0.000229	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.03e-05	0.000229	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.01e-05	0.000228	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.01e-05	0.000227	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2e-05	0.000226	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.99e-05	0.000225	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.98e-05	0.000224	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.97e-05	0.000223	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.96e-05	0.000222	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.96e-05	0.000222	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.96e-05	0.000221	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.91e-05	0.000216	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.88e-05	0.000213	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.87e-05	0.000212	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.87e-05	0.000211	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.87e-05	0.000211	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.87e-05	0.000211	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.83e-05	0.000207	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.83e-05	0.000207	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.82e-05	0.000206	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.81e-05	0.000204	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.79e-05	0.000202	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.78e-05	0.000202	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.74e-05	0.000196	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.73e-05	0.000196	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.73e-05	0.000196	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.71e-05	0.000193	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.7e-05	0.000192	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.66e-05	0.000187	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.65e-05	0.000187	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	0.000186	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.63e-05	0.000185	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.63e-05	0.000184	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.6e-05	0.000181	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.59e-05	0.00018	CbGpPWpGaD
Glyburide—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	1.57e-05	0.000178	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.56e-05	0.000177	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.56e-05	0.000176	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—ALB—chronic obstructive pulmonary disease	1.56e-05	0.000176	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.54e-05	0.000174	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.52e-05	0.000172	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.51e-05	0.000171	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—ALB—chronic obstructive pulmonary disease	1.51e-05	0.000171	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.49e-05	0.000169	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.49e-05	0.000168	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.49e-05	0.000168	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.47e-05	0.000166	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.47e-05	0.000166	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—NOS3—chronic obstructive pulmonary disease	1.44e-05	0.000163	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.43e-05	0.000162	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.4e-05	0.000158	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.37e-05	0.000155	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.36e-05	0.000154	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.36e-05	0.000153	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.35e-05	0.000153	CbGpPWpGaD
Glyburide—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	1.31e-05	0.000148	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.26e-05	0.000143	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.24e-05	0.00014	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.24e-05	0.00014	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.23e-05	0.000139	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ALB—chronic obstructive pulmonary disease	1.23e-05	0.000139	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.22e-05	0.000138	CbGpPWpGaD
Glyburide—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.21e-05	0.000137	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.21e-05	0.000136	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000135	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.18e-05	0.000134	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ALB—chronic obstructive pulmonary disease	1.18e-05	0.000133	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—NOS3—chronic obstructive pulmonary disease	1.18e-05	0.000133	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.13e-05	0.000127	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.12e-05	0.000127	CbGpPWpGaD
Glyburide—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.11e-05	0.000125	CbGpPWpGaD
Glyburide—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.1e-05	0.000125	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.1e-05	0.000124	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000123	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.07e-05	0.000121	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.06e-05	0.00012	CbGpPWpGaD
Glyburide—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	1.06e-05	0.000119	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.03e-05	0.000116	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.02e-05	0.000115	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.01e-05	0.000114	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1e-05	0.000113	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.89e-06	0.000112	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.89e-06	0.000112	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.82e-06	0.000111	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.66e-06	0.000109	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.38e-06	0.000106	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	9.24e-06	0.000104	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.22e-06	0.000104	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.12e-06	0.000103	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	9.02e-06	0.000102	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.9e-06	0.000101	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.84e-06	9.99e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	8.52e-06	9.64e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.47e-06	9.57e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.35e-06	9.44e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.31e-06	9.4e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	8.13e-06	9.19e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.82e-06	8.84e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.78e-06	8.8e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.77e-06	8.79e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.6e-06	8.59e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.5e-06	8.48e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.42e-06	8.39e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.38e-06	8.34e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.32e-06	8.27e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.99e-06	7.9e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	6.98e-06	7.89e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.93e-06	7.84e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	6.84e-06	7.73e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.84e-06	7.73e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.82e-06	7.71e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.62e-06	7.49e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.6e-06	7.46e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.52e-06	7.37e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.46e-06	7.31e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	6.44e-06	7.28e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.37e-06	7.2e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.04e-06	6.83e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.95e-06	6.73e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.48e-06	6.2e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	5.26e-06	5.94e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	4.8e-06	5.42e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.57e-06	5.17e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.51e-06	5.1e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.5e-06	5.09e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.39e-06	4.97e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.31e-06	4.87e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.2e-06	4.75e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.2e-06	4.75e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.11e-06	4.64e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.98e-06	4.5e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.93e-06	4.44e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.71e-06	3.06e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.59e-06	2.93e-05	CbGpPWpGaD
